Anticancer Bioscience is a highly ambitious, emerging, fast-growing and international precision oncology company, led by a management team that has world-class expertise in cancer research, and in innovating genetic tools such as synthetic lethality and in the design of novel high-throughput screening approaches.

As well as access to the scientific expertise of the J. Michael Bishop Institute of Cancer Research, we are advised by leading scientists and clinicians in oncology.

Our commercial expertise is strengthened through the experience of our board.


Dun Yang PhD

Founder, president and CEO, Chengdu


Jing Zhang PhD

Co-founder, VP of High Throughput and High Content Screening, Chengdu


Hong Liu PhD

VP of Clinical Development, Chengdu and San Francisco



Shenqiu Zhang PhD

VP of Medical Statistics and Bioinformatics, St Andrews